Glaxosmithkline Pharmaceuticals Ltd Annually Results

Gross Sales

3,453.71

3,251.72

3,278.03

2,925.6

3,224.38

Excise Duty

0

0

0

0

0

Net Sales

3,453.71

3,251.72

3,278.03

2,925.6

3,224.38

Other Operating Income

0

0

0

0

0

Other Income

122.59

103.71

1,401.31

181.46

79.01

Total Income

3,576.3

3,355.43

4,679.34

3,107.06

3,303.39

Total Expenditure

2,688.63

2,448.4

2,516.15

2,500.06

2,908.62

PBIDT

887.67

907.03

2,163.19

607

394.77

Interest

1.8

1.81

2

3.53

6.34

PBDT

885.87

905.22

2,161.19

603.47

388.43

Depreciation

69.68

65.77

68.19

78.6

82.68

Minority Interest Before NP

0

0

0

0

0

Tax

237.59

247.13

407.69

158.67

260.17

Deferred Tax

-11.36

-18.37

-9.41

8.05

-47.62

Reported Profit After Tax

589.96

610.69

1,694.72

358.15

93.2

Minority Interest After NP

0

0

0

0

0

Net Profit after Minority Interest

589.96

610.69

1,694.72

358.15

93.2

Extra-ordinary Items

-101.81

1.79

1,319.47

-38.34

-50.91

Adjusted Profit After Extra-ordinary item

691.77

608.9

375.25

396.49

144.11

EPS (Unit Curr.)

41.14

36.08

100.04

21.14

5.5

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

320

320

900

300

400

Equity

169.41

169.41

169.41

169.41

169.41

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

25.7

27.89

65.99

20.74

12.24

PBDTM(%)

25.64

27.83

65.92

20.62

12.04

PATM(%)

17.08

18.78

51.69

12.24

2.89